I suggest you to read this post by PlentyParanoid.
DO not put much value on the 96 % reduction in duration. Calculated in similar manner Brilacidin had duration reduction of 100 %. Those numbers are based on medians and are, by their lonesome, utterly, frivolously useless.
So B-OM is better? That’s a ‘shock’. Good luck trying to get insurance to reimburse IV treatments for seven weeks when the alternative is an oral rinse.
We have a drug who's full potential hasn't even scratched the surface yet. B's potential is huge just like the deal were getting. B in the right oral formulation could end OM.